Tolerability, safety and efficacy in patients with Alzheimer's disease who are switched from donepezil to galantamine

被引：1
|
作者：
Kurz, AF
Gold, M
机构：
[1] Tech Univ Munich, D-8000 Munich, Germany
[2] Johnson & Johnson Pharmaceut Res & Dev, Titusville, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80679-1
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S202 / S203
页数：2
相关论文
共 50 条
  • [31] Safety and Tolerability of Donepezil at Doses up to 20 mg/dayResults from a Pilot Study in Patients with Alzheimer’s Disease
    Rachelle S. Doody
    Jody Corey-Bloom
    Richard Zhang
    Honglan Li
    John Ieni
    Rachel Schindler
    [J]. Drugs & Aging, 2008, 25 : 163 - 174
  • [32] First head to head study comparing the tolerability and satisfaction/ease of use of donepezil and galantamine in Alzheimer's disease
    Aarsland, D
    Alhainen, K
    Bullock, R
    Wetterberg, P
    Smith, R
    Soininen, H
    Murthy, A
    Zhang, R
    Bahra, R
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S384 - S384
  • [33] Safety and tolerability of high dose donepezil in patients with Alzheimer's disease: A preliminary report of a pilot study
    Shua-Haim, JR
    Pass, M
    Patel, S
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 356 - 357
  • [34] Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease
    Li, Dan-Dan
    Zhang, Ya-Hong
    Zhang, Wei
    Zhao, Pu
    [J]. FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [35] Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine -: Reply
    Lopez-Pousa, Secundino
    Garre-Olmo, Josep
    Vilalta-Franch, Joan
    [J]. AGE AND AGEING, 2007, 36 (02) : 235 - 235
  • [36] Safety and tolerability of once-daily galantamine extended release in patients with mild to moderate Alzheimer's disease
    Brodaty, H
    Schwalen, S
    Gold, M
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S209 - S209
  • [37] Safety of donepezil in korean patients with severe alzheimer's disease
    Park, H.
    Kim, J.
    Mun, J.
    Choi, Y.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E135 - E135
  • [38] Safety profile of donepezil in patients with severe Alzheimer's disease
    Mcrae, T.
    Richardson, S. A.
    Surick, I. W.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 57 - 57
  • [39] Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease
    Waldemar, G.
    Hyvarinen, M.
    Wetterberg, P.
    Korner, A.
    Lehto, H.
    Josiassen, M. K.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 188 - 188
  • [40] Safety and tolerability of donepezil at doses up to 20 mg/day - Results from a pilot study in patients with Alzheimer's disease
    Doody, Rachelle S.
    Corey-Bloom, Jody
    Zhang, Richard
    Li, Honglan
    Ieni, John
    Schindler, Rachel
    [J]. DRUGS & AGING, 2008, 25 (02) : 163 - 174
12345